Drug makers agonizing over future profits

Published: 2012-05-18 06:58:00

Updated: 2012-05-18 06:58:00

The possible reclassification of 20 over-the-counter (OTC) drugs as “quasi-drugs,” is seen as a much needed move for the industry, but pharmaceutical companies are still uncertain over the success in convenient stores.

Consumers will be able to buy 20 OTC drugs such as cold medicines, analgesi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK